المؤلفون: Hoffmann, Lone, Ehmsen, ML., Hansen, J., Hansen, R., Knap, MM., Mortensen, HR., Poulsen, PR., Ravkilde, T., Rose, HK., Schmidt, HH., Worm, ES., Møller, DS.

المصدر: In Radiotherapy and Oncology November 2023 188

المؤلفون: Mortensen HR; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Populaire P; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Hoffmann L; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Moeller DS; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Appelt A; University of Leeds, Leeds, UK., Nafteux P; University Hospitals Leuven, Department of Thoracic Surgery, Belgium., Muijs CT; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Grau C; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, London, UK., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany., Defraene G; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, the Netherlands., Clarke CS; Research Dept. of Primary Care and Population Health, University College London, London, UK., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland., Korevaar EW; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Haustermans K; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Nordsmark M; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Achiam MP; Dept. Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Markar SR; Department of General Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgery, University of Oxford, Oxford, UK., Radhakrishna G; The Christie, Manchester, United Kingdom., Berbee M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Scartoni D; Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Orlandi E; National Center for Oncological Hadrontherapy (CNAO), Radiation Oncology Clinical Department, Pavia, Italy., Doyen J; Centre Antoine Lacassagne, Nice, France., Gregoire V; Centre Léon Bérard, 28 rue Laennec, Lyon 69373 Cedex 08, France., Crehange G; PSL Research University, RadiationOncology Department, Institut Curie, Paris/Orsay, France., Langendijk J; Department of Radiation Oncology, UniversityMedicalCentreGroningen, Groningen, The Netherlands., Lorgelly P; University of Auckland, Waipara Taumata Rau, Auckland, New Zealand., Blommenstein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR, The Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands., Byskov CS; Department of Oncology and Medical physics, Aarhus University Hospital, Aarhus, Denmark., Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Jensen MF; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Freixas GV; Maastro Proton Therapy, Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany.

مؤلفون مشاركون: PROTECT consortium

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109980. Date of Electronic Publication: 2023 Nov 05.

نوع المنشور: Clinical Trial Protocol; Letter

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/surgery , Neoadjuvant Therapy*, Humans ; Chemoradiotherapy ; Esophagectomy ; Protons ; Clinical Trials, Phase III as Topic ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

المؤلفون: Shamshad M; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark., Møller DS; Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Mortensen HR; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Ehmsen ML; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Jensen MF; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Hoffmann L; Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Aug; Vol. 61 (8), pp. 994-1003. Date of Electronic Publication: 2022 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/radiotherapy , Proton Therapy*/methods, Humans ; Radiotherapy Dosage ; Retrospective Studies

المؤلفون: Hoffmann L; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark. Electronic address: Lone.Hoffmann@aarhus.rm.dk., Mortensen H; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Shamshad M; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Berbee M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Bizzocchi N; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Defraene G; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium., Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Fiorini F; Rutherford Cancer Centre, Shinfield, Reading, UK., Haustermans K; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Hulley R; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Korevaar EW; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Clarke M; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Makocki S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Murray L; Rutherford Cancer Centre, Shinfield, Reading, UK., Nicholas O; South West Wales Cancer Centre, Swansea University Board and Swansea University Medical School, UK., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Radhakrishna G; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Thomas M; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Vilches-Freixas G; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Visser S; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland., Møller DS; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Jul; Vol. 172, pp. 32-41. Date of Electronic Publication: 2022 May 02.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/diagnostic imaging , Esophageal Neoplasms*/radiotherapy , Proton Therapy*/methods , Radiotherapy, Intensity-Modulated*/methods, Humans ; Protons ; Radiotherapy Planning, Computer-Assisted/methods